April 2014 FDA Recall Drug by Wockhardt Usa Inc.
D-1300-2014 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Wockhardt Usa Inc. on April 1, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1300-2014

Reason for Recall
Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
Initiated
04-01-2014
Reported
05-14-2014
Quantity
109,744 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.

Batch or Lot Expiration Information

Lot# : LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15